Literature DB >> 9390008

The melanocortin 1, 3, 4 or 5 receptors do not have a binding epitope for ACTH beyond the sequence of alpha-MSH.

H B Schiöth1, R Muceniece, M Larsson, J E Wikberg.   

Abstract

ACTH(1-39), and several shorter N- and/or C-terminally truncated fragments of ACTH, with and without N-terminal acetylation and/or C-terminal amidation, were tested for binding on a single eukaryotic cell line transiently and independently expressing the melanocortin MC1, MC3, MC4 and MC5 receptors. The results show that none of these MC receptors has specific binding epitopes for the ACTH peptides beyond the amino acid sequence of alpha-MSH, when tested for their ability to compete with 125I-labelled [Nle4,D-Phe7]alpha-MSH and ACTH. The MC3 receptor favours the natural desacetylated N-terminal end of the ACTH peptides, and it has generally more than 10-fold higher affinity for the ACTH peptides than the MC4 receptor. Considering earlier anatomical localisation data, together with the present data, we suggest that the MC3 receptor is the most likely candidate of the MC receptors to mediate the short-loop negative feedback release of corticotrophin-releasing factor (CRF) caused by ACTH/MSH peptides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9390008     DOI: 10.1677/joe.0.1550073

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

Review 1.  Promising new approaches to the management of obesity.

Authors:  I L Mertens; L F Van Gaal
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 2.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

3.  Adrenocorticotropic hormone enhances the masculinity of an electric communication signal by modulating the waveform and timing of action potentials within individual cells.

Authors:  Michael R Markham; Philip K Stoddard
Journal:  J Neurosci       Date:  2005-09-21       Impact factor: 6.167

4.  The melanocortin receptor subtypes in chicken have high preference to ACTH-derived peptides.

Authors:  Maria K Ling; Eri Hotta; Zuzana Kilianova; Tatjana Haitina; Aneta Ringholm; Lisa Johansson; Nicole Gallo-Payet; Sakae Takeuchi; Helgi B Schiöth
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

5.  Cloning, tissue distribution, pharmacology and three-dimensional modelling of melanocortin receptors 4 and 5 in rainbow trout suggest close evolutionary relationship of these subtypes.

Authors:  Tatjana Haitina; Janis Klovins; Jan Andersson; Robert Fredriksson; Malin C Lagerström; Dan Larhammar; Earl T Larson; Helgi B Schiöth
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

6.  Melanocortin systems on pigment dispersion in fish chromatophores.

Authors:  Yuki Kobayashi; Kanta Mizusawa; Yumiko Saito; Akiyoshi Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2012-02-01       Impact factor: 5.555

7.  Pharmacodynamics and tolerability of repository corticotropin injection in healthy human subjects: A comparison with intravenous methylprednisolone.

Authors:  Ritu Lal; Stacie Bell; Rashida Challenger; Vakessa Hammock; Mary Nyberg; Dima Decker; Patrice M Becker; David Young
Journal:  J Clin Pharmacol       Date:  2015-09-10       Impact factor: 3.126

8.  Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases.

Authors:  Carl Spana; Andrew W Taylor; David G Yee; Marie Makhlina; Wei Yang; John Dodd
Journal:  Front Pharmacol       Date:  2019-01-14       Impact factor: 5.810

9.  Functional characterization of two melanocortin (MC) receptors in lamprey showing orthology to the MC1 and MC4 receptor subtypes.

Authors:  Tatjana Haitina; Janis Klovins; Akiyoshi Takahashi; Maja Löwgren; Aneta Ringholm; Johan Enberg; Hiroshi Kawauchi; Earl T Larson; Robert Fredriksson; Helgi B Schiöth
Journal:  BMC Evol Biol       Date:  2007-06-29       Impact factor: 3.260

10.  Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept.

Authors:  Dima A Decker; Paul Higgins; Kyle Hayes; Chris Bollinger; Patrice Becker; Dale Wright
Journal:  BMC Musculoskelet Disord       Date:  2020-08-31       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.